Analysis: Vaishali Pharma Limited

NSE:VAISHALI Pharmaceuticals Bulk Drugs & Formulation Market cap: ₹90 cr

Research report

companyname: Vaishali Pharma Limited ticker: VAISHALI sector: Pharmaceuticals Vaishali Pharma Limited is a Mumbai-based pharmaceutical company founded in 1989. It does not own its own manufacturing plants. Instead, it operates an asset-light model where it contracts with more than 22 third-party manufacturing sites across India, each selected for its specific capabilities and certifications, to produce products that Vaishali then markets and exports under its own brands or its customers' brands...

Read the full report →
RS rating: 74 Stage: Stage 2

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Vaishali Pharma Limited and 4,900+ companies.

Sign in
5-day free pass. No card required.